Understanding treatment pathways for Alzheimer’s Disease

by clairenicholson078 | Jul 24, 2023 | Uncategorized

Understanding treatment pathways for Alzheimer’s Disease In the realm of neurological disorders, Alzheimer’s Disease (AD) stands as one of the most challenging and devastating conditions of our time. With its progressive nature and profound impact on...

Identification and management of Alzheimer’s Disease (AD)Diadem Presents Data at 2023 AAIC® Showing Its AlzoSure® Blood Test Can Identify Patients at High Risk of Significant Cognitive Decline Due to Alzheimer’s DiseaseIdentification and management of Alzheimer’s Disease (AD)

by clairenicholson078 | Jul 18, 2023 | Uncategorized

Identification and management of Alzheimer’s Disease (AD)

by clairenicholson078 | May 3, 2023 | Uncategorized

Diadem Reports New Data Showing Its AlzoSure^® Predict Blood Test Can Accurately Identify “Rapid Progressors” Who Will Develop Alzheimer’s Disease Within Two Years

by Claire | Jan 9, 2023 | Uncategorized

At CTAD 2022 Diadem Highlights How Its AlzoSure^® Predict Prognostic Blood Test for Alzheimer’s Disease Will Help Patients and Facilitate Development of New Therapies

by Claire | Dec 5, 2022 | Uncategorized

Diadem Builds Out Executive Team As It Prepares for Commercialization of Its AlzoSure^® Predict Prognostic Test for Alzheimer’s Disease

by Claire | Nov 21, 2022 | Uncategorized

Diadem Builds Out Executive Team As It Prepares for Commercialization of Its AlzoSure® Predict Prognostic Test for Alzheimer’s Disease —Diadem to Participate in the 15th Clinical Trials on Alzheimer’s Disease (CTAD) Conference— Milan, Italy, November 21, 2022 – Diadem...